Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Human Megakaryocyte Progenitor Assay
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of a multi-pathogen chimeritope vaccine for tick borne diseases
Properties and Functions of the Melanin Skin Pigment
In Situ Metabolism of Branched Chain Amino Acids
Targeted Infusion Project: Lincoln University Bioinformatics Program (LUBi)
Seminar on Stochastic Processes
Recently added grants:
Tobacco and Environmental Carcinogenesis Program
Community Outreach and Engagement
Developmental Funds
Shared Resource Management
Leadership, Planning and Evaluation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI034817-03
Application #
2070001
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-09-01
Project End
1997-07-31
Budget Start
1996-01-01
Budget End
1997-07-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1996
R44 AI
Development of Human Megakaryocyte Progenitor Assay
Murphy, Martin J. / Hipple Cancer Research Corporation
NIH 1995
R44 AI
Development of Human Megakaryocyte Progenitor Assay
Murphy, Martin J. / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant